453 related articles for article (PubMed ID: 16765539)
1. Evolution of canine parvovirus--a need for new vaccines?
Truyen U
Vet Microbiol; 2006 Oct; 117(1):9-13. PubMed ID: 16765539
[TBL] [Abstract][Full Text] [Related]
2. [Canine parvovirus: recent knowledge of the origin and development of a viral pathogen].
Truyen U
Tierarztl Prax; 1994 Dec; 22(6):579-84. PubMed ID: 7716757
[TBL] [Abstract][Full Text] [Related]
3. Comparison of selected canine vaccines for their ability to induce protective immunity against canine parvovirus infection.
Larson LJ; Schultz RD
Am J Vet Res; 1997 Apr; 58(4):360-3. PubMed ID: 9099379
[TBL] [Abstract][Full Text] [Related]
4. [Evolution of canine parvovirus: loss and gain of the feline host].
Truyen U
Tierarztl Prax; 1996 Jun; 24(3):316-8. PubMed ID: 8767195
[TBL] [Abstract][Full Text] [Related]
5. Vaccination with canine parvovirus type 2 (CPV-2) protects against challenge with virulent CPV-2b and CPV-2c.
Siedek EM; Schmidt H; Sture GH; Raue R
Berl Munch Tierarztl Wochenschr; 2011; 124(1-2):58-64. PubMed ID: 21306055
[TBL] [Abstract][Full Text] [Related]
6. Antibody levels and protection to canine parvovirus type 2.
Elia G; Cavalli A; Cirone F; Lorusso E; Camero M; Buonavoglia D; Tempesta M
J Vet Med B Infect Dis Vet Public Health; 2005; 52(7-8):320-2. PubMed ID: 16316392
[TBL] [Abstract][Full Text] [Related]
7. Antigenic and genetic analysis of canine parvoviruses in southern Africa.
Steinel A; Venter EH; Van Vuuren M; Parrish CR; Truyen U
Onderstepoort J Vet Res; 1998 Dec; 65(4):239-42. PubMed ID: 10192835
[TBL] [Abstract][Full Text] [Related]
8. Canine parvovirus type 2 vaccine protects against virulent challenge with type 2c virus.
Spibey N; Greenwood NM; Sutton D; Chalmers WS; Tarpey I
Vet Microbiol; 2008 Apr; 128(1-2):48-55. PubMed ID: 18006253
[TBL] [Abstract][Full Text] [Related]
9. Three-year rabies duration of immunity in dogs following vaccination with a core combination vaccine against canine distemper virus, canine adenovirus type-1, canine parvovirus, and rabies virus.
Lakshmanan N; Gore TC; Duncan KL; Coyne MJ; Lum MA; Sterner FJ
Vet Ther; 2006; 7(3):223-31. PubMed ID: 17039445
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the antigenic relationships among canine parvovirus type 2 variants.
Cavalli A; Martella V; Desario C; Camero M; Bellacicco AL; De Palo P; Decaro N; Elia G; Buonavoglia C
Clin Vaccine Immunol; 2008 Mar; 15(3):534-9. PubMed ID: 18160619
[TBL] [Abstract][Full Text] [Related]
11. Thoughts on vaccination protocols.
Petzel B
J Am Vet Med Assoc; 2000 Nov; 217(10):1459. PubMed ID: 11128531
[No Abstract] [Full Text] [Related]
12. Thoughts on vaccination protocols.
McLaughlin MA
J Am Vet Med Assoc; 2000 Nov; 217(10):1458-9. PubMed ID: 11128530
[No Abstract] [Full Text] [Related]
13. Do two current canine parvovirus type 2 and 2b vaccines provide protection against the new type 2c variant?
Larson LJ; Schultz RD
Vet Ther; 2008; 9(2):94-101. PubMed ID: 18597247
[TBL] [Abstract][Full Text] [Related]
14. Maternally-derived antibodies in pups and protection from canine parvovirus infection.
Decaro N; Campolo M; Desario C; Elia G; Martella V; Lorusso E; Buonavoglia C
Biologicals; 2005 Dec; 33(4):261-7. PubMed ID: 16168665
[TBL] [Abstract][Full Text] [Related]
15. Intranasal vaccination of pups in the presence of maternally derived antibodies to canine parvovirus (CPV). Evaluation of minimal immunizing dose.
Buonavoglia C; Cavalli A; Tempesta M; Voight V; Buonavoglia D; Corrente M; Sagazio P
New Microbiol; 1995 Oct; 18(4):371-5. PubMed ID: 8590389
[TBL] [Abstract][Full Text] [Related]
16. Evidence for immunisation failure in vaccinated adult dogs infected with canine parvovirus type 2c.
Decaro N; Desario C; Elia G; Martella V; Mari V; Lavazza A; Nardi M; Buonavoglia C
New Microbiol; 2008 Jan; 31(1):125-30. PubMed ID: 18437851
[TBL] [Abstract][Full Text] [Related]
17. Three-year duration of immunity in dogs following vaccination against canine adenovirus type-1, canine parvovirus, and canine distemper virus.
Gore TC; Lakshmanan N; Duncan KL; Coyne MJ; Lum MA; Sterner FJ
Vet Ther; 2005; 6(1):5-14. PubMed ID: 15906266
[TBL] [Abstract][Full Text] [Related]
18. Intranasal vaccination of pups with maternally derived antibodies with a modified live canine parvovirus.
Buonavoglia C; Cavalli A; Gravino E; Voigt V; Buonavoglia D; de Caprariis D
Zentralbl Veterinarmed B; 1994 Mar; 41(1):3-8. PubMed ID: 7941844
[TBL] [Abstract][Full Text] [Related]
19. Vaccination of dogs with canine parvovirus type 2b (CPV-2b) induces neutralising antibody responses to CPV-2a and CPV-2c.
Wilson S; Illambas J; Siedek E; Stirling C; Thomas A; Plevová E; Sture G; Salt J
Vaccine; 2014 Sep; 32(42):5420-4. PubMed ID: 25148778
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a canine parvovirus strain isolated from an adult dog.
Cavalli A; Bozzo G; Decaro N; Tinelli A; Aliberti A; Buonavoglia D
New Microbiol; 2001 Jul; 24(3):239-42. PubMed ID: 11497080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
